Chest Radiation Ups Risk of Breast Cancer in Young Women
Last Updated: 2010-04-05 17:19:03 -0400 (Reuters Health)
NEW YORK (Reuters Health) - Women treated with chest radiation in childhood or adolescence are at increased risk for breast cancer at a young age, and their risk does not appear to plateau over time, according to a systematic literature review in the April 6th Annals of Internal Medicine.
Regular screening for breast cancer is a must in these women, senior author Dr. Kevin C. Oeffinger, from Memorial Sloan-Kettering Cancer Center, New York, and colleagues note - but radiotherapy usually causes their breast tissue to become dense, making surveillance more complicated.
The researchers base their findings on a systematic review of relevant studies identified through a search of MEDLINE, EMBASE, the Cochrane Library, and the Cumulative Index to Nursing and Allied Health Literature from 1966 to December 2008.
The researchers included articles that answered any of three questions: 1) What is the rate and excess risk of breast cancer in women treated with chest radiation in childhood or young adulthood? 2) What are the clinical features and treatment outcomes in such women who develop breast cancer compared with breast cancer patients in the general population? 3) What are the possible benefits and harms of breast cancer surveillance in such women?
Eleven retrospective cohort studies (with over 14,000 women) and 3 case-control studies addressed the first question. In women treated with chest radiation at a young age, the standardized incidence ratios for breast cancer ranged from 13.3 to 55.5. The cumulative rate of breast cancer by age 40 to 45 years was between 13% and 20%.
Eight studies featuring 400 women addressed the second question. Their data suggest that breast cancer characteristics of women treated with chest radiation in childhood are similar to those of women in the general population.
For the final question, the investigators used data from two retrospective studies (with 92 women) and 3 prospective studies (in 320 women). Data from these reports indicate that mammography can be used for breast cancer surveillance in the study population, although sensitivity is limited.
Because the best means for imaging breast tissue in these women isn't clear yet, the benefits and harms of surveillance also remain unclear.
In addition, as the authors point out, research is needed to assess "how estimates of risk and outcome might change, given use of lower radiation doses in contemporary treatment."
The study was funded by the National Cancer Institute.
Ann Intern Med 2010;152:445-455.
Copyright © 2010 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.
